Mississippi Made Mailing Abortion Pills a Drug-Trafficking Crime.

What happens when a prescription arrives in the mail with no doctor visit behind it?

Rep. Celeste Hurst, who carried an amendment to HB1613, says that's exactly the hole this bill closes. Chemical abortion prescriptions, she argued, are "being mailed out without any doctor oversight" and without age verification.

HB1613 does two things at once, and they deserve to be separated clearly.

The bill tightens Mississippi's aggravated drug-trafficking statute by adding a dosage-unit threshold, 267 units or more, alongside the existing 200-gram trigger. Cross that threshold with a Schedule I or II substance, and a trafficker faces a mandatory 25-years-to-life sentence.

The bill also creates a new crime for distributing or prescribing chemical abortion drugs, like mifepristone and misoprostol, with intent to cause an abortion. It's punishable by one to ten years, and it's enforceable civilly by the Attorney General on top of the criminal penalty. The provision is written with explicit exceptions for legitimate medical care: miscarriage management, ectopic pregnancy, fetal demise, and more. It targets the medical providers and distributors sending these drugs, not the patients receiving them.

Reproductive Freedom for All has warned this approach will create the same access problems Louisiana saw after passing similar legislation, saying it has "wreaked havoc on access to abortion care, pregnancy care, fertility care, and other medical care" there. Their concern is that the exceptions written into the law won't function cleanly in practice, especially for miscarriage and postpartum care that can look procedurally similar to what the bill targets.

That's a fair concern to raise, and it's also exactly why the medical exceptions matter as much as the crime itself. Whether Mississippi's exceptions hold up better than Louisiana's in practice is something to watch, not assume either way.

Mississippi isn't alone here. Students for Life Action counts Mississippi as the second state this session to pass this kind of law, part of what pro-life groups describe as a coordinated multistate push. But the legal ground under it hasn't stopped moving. The FDA's own approval and regulation of mifepristone sits in unsettled, actively litigated federal-preemption territory, and the Attorney General's civil-enforcement mechanism here is broad enough that how it actually gets used in practice will matter as much as what the statute says on paper.

HB1613 is two conservative priorities in one bill: tougher trafficking penalties and a new check on unsupervised abortion-drug distribution, with real medical exceptions built in. The trafficking piece is straightforward. The abortion-drug piece is where Mississippi is running ahead of settled law, alongside a small handful of other states doing the same thing at the same time.

This is our read of the law. We encourage you to read it yourself and reach your own conclusions.